Harrow HROW
NASDAQ HROW
$30.48 -0.13 (-0.42%)
At close: Oct 2, 2026 · 4:00 PM EDT

Harrow (HROW) Return on Equity [ROE] (2012 - 2026)

Updated

Harrow's Return on Equity [ROE] came in at -153.64% for Q2 2026, down 134.23 percentage points from -19.41% a year earlier and down 125.94 percentage points from the prior quarter.

Analysis

Harrow (HROW) Return on Equity [ROE] (2012 - 2026) Analysis & Trends

For FY2025, Harrow's Return on Equity [ROE] was -8.44%, up 16.58 percentage points from FY2024.

  • Return on Equity [ROE] has increased in each of the last four years, with a five-year change of +4.16 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Equity [ROE] was -25.03% in FY2024 (+24.97 pp), -50.00% in FY2023 (+23.81 pp), -73.80% in FY2022 (+21.57 pp) and -95.38% in FY2021 (-82.77 pp).
  • The Q2 2026 figure represents the lowest quarterly Return on Equity [ROE] since Q3 2022.
  • Year-over-year, Return on Equity [ROE] increased in six of the last eight quarters, with an average year-over-year change of -3.39 percentage points.
  • The fastest year-over-year change in Return on Equity [ROE] over five years came in Q3 2023 (a gain of 692.04 percentage points), and the weakest in Q3 2022 (a drop of 672.85 percentage points).
  • Business Quant data shows HROW's Return on Equity [ROE] at -27.70% (Q1 2026), -2.75% (Q4 2025) and -10.36% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 Harrow 1.14 Bn 816.41 Mn 50.36 Mn -153.64%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -153.64%
Mar 31, 2026 -27.70%
Dec 31, 2025 -2.75%
Sep 30, 2025 -10.36%
Jun 30, 2025 -19.41%
Mar 31, 2025 -34.60%
Dec 31, 2024 -27.55%
Sep 30, 2024 -57.70%
Jun 30, 2024 -56.73%
Mar 31, 2024 -47.98%
Dec 31, 2023 -33.48%
Sep 30, 2023 -29.16%
Jun 30, 2023 -74.72%
Mar 31, 2023 -75.01%
Dec 31, 2022 -100.25%
Sep 30, 2022 -721.20%
Jun 30, 2022 -322.84%
Mar 31, 2022 -199.95%
Dec 31, 2021 -132.58%
Sep 30, 2021 -48.35%
API Access

Harrow Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=HROW&period=max&api_key=YOUR_API_KEY